Informa plc (LON:INF - Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 799.66 ($10.76) and traded as high as GBX 889.60 ($11.97). Informa shares last traded at GBX 880 ($11.84), with a volume of 2,065,498 shares.
Wall Street Analyst Weigh In
INF has been the subject of several analyst reports. JPMorgan Chase & Co. started coverage on shares of Informa in a report on Tuesday, July 29th. They set an "overweight" rating and a GBX 1,020 ($13.72) price target for the company. Shore Capital reaffirmed a "buy" rating and set a GBX 930 ($12.51) price objective on shares of Informa in a report on Friday, May 23rd.
Read Our Latest Analysis on INF
Informa Stock Performance
The company has a debt-to-equity ratio of 31.98, a quick ratio of 1.70 and a current ratio of 0.56. The firm has a market cap of £11.46 billion, a P/E ratio of 37.50, a PEG ratio of 0.75 and a beta of 1.12. The stock's 50-day moving average is GBX 824 and its 200 day moving average is GBX 800.43.
Informa (LON:INF - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported GBX 30.10 ($0.40) earnings per share for the quarter. Informa had a net margin of 9.30% and a return on equity of 4.75%. On average, research analysts predict that Informa plc will post 59.3240265 earnings per share for the current year.
Insider Activity
In related news, insider Stephen A. Carter sold 406,936 shares of Informa stock in a transaction dated Tuesday, July 29th. The stock was sold at an average price of GBX 865 ($11.63), for a total value of £3,519,996.40 ($4,734,359.65). 0.53% of the stock is owned by company insiders.
About Informa
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
Read More
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.